Your email has been successfully added to our mailing list.

×
0 0 0 0 0 0 0.0182403433476395 0.0185354077253218
Stock impact report

Medigene expands partnership with bluebird bio [Seeking Alpha]

bluebird bio, Inc. (BLUE) 
Last bluebird bio, inc. earnings: 2/18 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: investor.bluebirdbio.com/investor-overview
Company Research Source: Seeking Alpha
Medigene expands partnership with bluebird bioGerman biotech Medigene AGexpands its 2016 strategic alliance with bluebird bio (NASDAQ:BLUE), increasing the number of T cell receptor projects to six from four.Medigene will receive an additional upfront payment of $8M plus R&D funding, up to $250M in milestone payments per program and double-digit royalties on net sales.Previously:Medigene and bluebird bio team up in cancer immunotherapy (Sept. 29, 2016)Click to subscribe to real-time analytics on BLUENow read:Bluebird Bio Impresses Yet Again With Gene Therapy Platform » Show less Read more
Impact Snapshot
Event Time:
BLUE
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for BLUE alerts
Opt-in for
BLUE alerts

from News Quantified
Opt-in for
BLUE alerts

from News Quantified